| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing rituximab (medicinal product) |
Has active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| rituximab 10 mg/ml, injektionskoncentrat, flaska 10 ml |
Has active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Some |
|
| rituximab 10 mg/ml, infusionskoncentrat, flaska 50 ml |
Has active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Some |
|
| Rituximab 500mg infusion concentrate vial |
Has active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Some |
|
| Rituximab 100mg infusion concentrate vial |
Has active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to rituximab administered by infusion |
Causative agent |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing rituximab in parenteral dose form (medicinal product form) |
Has active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Some |
7 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Some |
6 |
| Rituximab therapy (procedure) |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Some |
2 |
| rituximab 100 mg/10 ml, infusionsvätska, lösning, flaska |
Has basis of strength substance (attribute) |
False |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| rituximab 100 mg/10 ml, infusionsvätska, lösning, flaska |
Has precise active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| rituximab 500 mg/50 ml, infusionsvätska, lösning, flaska |
Has basis of strength substance (attribute) |
False |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| rituximab 500 mg/50 ml, infusionsvätska, lösning, flaska |
Has precise active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Rituximab only product |
Has active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Rituximab only product in parenteral dose form |
Has active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Some |
2 |
| Rituximab 10 mg/mL solution for injection |
Has precise active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Rituximab 10 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Some |
1 |